An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac)
Clinical trial NCT05407142 · UNKNOWN
Trial details
- NCT number
- NCT05407142
- Sponsor
- Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-07
- Primary completion
- 2023-06-01
- Enrollment
- 29000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.